Braxia

Braxia Nears Profits Amid North American Expansion

Braxia Health clinics continued to see steady growth through the quarter, and the company expanded its research trials. Braxia Scientific Corp. (CSE: BRAX, OTC: BRAXF) posted steady growth in its fiscal first quarter, good news in its quest for profitability after its recent acquisition of Florida-based KetaMD. The Canadian research and telehealth company filed its financial and …

Braxia Nears Profits Amid North American Expansion Read More »

Braxia Buys KetaMD in Deal Treasured at $6.2 Million

Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF), acquired KetaMD, Inc. in a bid to expand ketamine-based psychedelic treatment for depression and other mental health challenges. The overall value of the deal is $6.2 million in a combination of common shares and convertible notes. KetaMD was founded by psychedelic pioneers Zappy Zapolin and Warren Gumpel, along with mindfulness instructor …

Braxia Buys KetaMD in Deal Treasured at $6.2 Million Read More »